Register for your FREE account now and join thousands of oncology professionals who stay informed about patient care issues, practical oncology-care management techniques, and drug administration and dosage information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

April 2011 Issue of ONA

April 2011 Issue of ONA

For Your Patient

Radiation therapy: What it is and how it works

This installment includes information on radiation therapy and resources for patients undergoing radiotherapy.
 

Continuing Education

Lynch syndrome: Identifying patients at risk for HNPCC

Identifying families at risk improves screening and counseling of patients at risk for hereditary nonpolyposis colorectal cancer.
 

In the News

AICR "plates" new dietary guidelines

The American Institute for Cancer Research is urging people to think about how the famous USDA food pyramid should actually translate to the plate in ...
 

Sperm retrieval offers fertility hope

Adult men who were thought to be rendered sterile due to chemotherapy for childhood cancer may be able to reproduce with the help of a ...
 

FDA approves 3-D, wireless imaging modes

In two separate decisions, the FDA has approved both the first three-dimensional (3-D) imaging system for mammography and the first diagnostic radiology application for mobile ...
 

Patient Advisor: New health Web site for consumers

Patient Advisor (www.MPRPatientAdvisor.com) is a collaboration of Monthly Prescribing Reference (MPR, published by Haymarket Media) and AnswersMedia, LLC.
 

Advisor Forum

Oncology Nurse Advisor Forum - March/April 2011

The Advisor Forum panel answers nurses' questions about patient care, treatment regimens, and oncology nursing.
 

Features

Survivors of pediatric cancers: How much do they know?

As more children survive pediatric cancers, oncology nurses are challenged to learn about past cancer histories.
 

Issues in Cancer Survivorship

Total XV protocol significantly improves survival in older adolescents with leukemia

Once considered to be a poor risk group, adolescents with ALL had higher overall survival rates with a new treatment protocol.
 

Stat Consult

Fluorouracil IV (5-FU, Adrucil)

Fluorouracil is an antimetabolite antineoplastic agent indicated for colorectal, gastric, metastatic breast, metastatic colorectal, and pancreatic cancers.
 

Radiation and Your Patient

When is IMRT the right treatment for prostate cancer?

Accurate delivery of radiation means less exposure of healthy tissue and fewer side effects, but simpler therapies or no therapy at all may be more ...
 

Communication Challenges

The Family Meeting: Meeting the family where they are

Sometimes, despite our best efforts, we cannot convince the patient's family that the time for hope is gone.
 

From Cancer Care

The financial burden of cancer care

Cancer treatment incurs more than direct health care costs. These organizations can help your patients with the extra expenses of cancer treatment.
 

Ask a Pharmacist

Parenteral iron test doses and hot flushes on tamoxifen

Who should receive a test dose prior to a full-dose iron infusion? How can hot flushes be managed in women on tamoxifen therapy?
 

The Total Patient

On call with Dr. Bovine: Clowning around helps young patients cope with cancer

Glen Heroy talks about his years as a clown who offered pediatric oncology patients a chance to forget they were sick, if only for 5 ...
 

Reflections

Our pal Joey

A young boy is determined to get the answers to questions about his father's radiation treatments, and the treatment team is happy to oblige.
 

Web Exclusives

BI-RADS and breast MRI useful in predicting malignancy

Delicia Honen Yard May 30, 2012

The Breast Imaging Reporting and Data System (BI-RADS) terminology is useful in predicting malignancy in breast lesions detected with MRI.
 

Posttransplant lenalidomide can slow down multiple myeloma

Delicia Honen Yard May 29, 2012

Lenalidomide use after autologous stem-cell transplant significantly improved progression-free and overall survival in patients with myeloma.
 

Melanoma genome study implicates sun and new genetic culprits

Delicia Honen Yard May 28, 2012

Genetic mutations increased along with chronic sun exposure in persons with melanoma, and yet another gene may contribute to disease risk as well.
 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions